The U.S. Department of Health and Human Services (HHS) and the Food and Drug Administration (FDA) have announced a review of the nutrient content in infant formula. This initiative aims to ensure that the nutritional standards meet the evolving needs of infants. The review comes after recent concerns about the quality and safety of infant formula products. Industry stakeholders, including manufacturers like Abbott Laboratories (ABT:NYSE), are closely monitoring the developments. The agencies plan to collaborate with experts to evaluate current guidelines and potentially update them based on the latest scientific evidence.
— new from Axios